Patents by Inventor Allan M. Green

Allan M. Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Verotoxin B subunit for immunization
    Patent number: 8367071
    Abstract: Methods for stimulating an immune response in a mammal by administering a toxin-antigen conjugate are provided. Pharmaceutical compositions and methods for treating an antigen-related state are also described.
    Type: Grant
    Filed: February 13, 2003
    Date of Patent: February 5, 2013
    Assignees: Inserm-Transfert, Universite Pierre et Marie Curie (UPMC)
    Inventor: Allan M. Green
  • THERAPIES FOR COGNITION AND LEARNING ENHANCEMENT
    Publication number: 20090252704
    Abstract: The invention relates to a combination comprising an amount of an NO donor, such as ISDN, and/or an amount of another pharmaceutical agent that enhances neurotransmission or which acts as neuroprotectants such as memantine, clomethiazole and tacrine. These compositions can be used in producing cognition and learning enhancement, whereby the invention also provides for a new method of treatment of Alzheimer's disease and related neurodegenerative disorders.
    Type: Application
    Filed: January 14, 2009
    Publication date: October 8, 2009
    Inventors: Allan M. GREEN, Robert Bender
  • Labeled Macrophages and Methods of Use Thereof
    Publication number: 20090016956
    Abstract: Methods of making and using labeled macrophages are described.
    Type: Application
    Filed: April 28, 2008
    Publication date: January 15, 2009
    Inventors: Robert Bender, Allan M. Green, Perry Kim, Robert Kisilevsky, Douglas S. McNair, Shui-pang Tam
  • Compounds and methods for modulating cerebral amyloid angiopathy
    Publication number: 20080317834
    Abstract: The invention provides methods of inhibiting cerebral amyloid angiopathy. The invention further provides methods of treating a disease state characterized by cerebral amyloid angiopathy in a subject.
    Type: Application
    Filed: November 10, 2003
    Publication date: December 25, 2008
    Applicant: Neurochem (International) Limited
    Inventors: Allan M. Green, Francine Gervais
  • Methods for using annexin for detecting cell death in vivo and treating associated conditions
    Patent number: 6843980
    Abstract: The present invention provides methods and compositions for imaging cell death in vivo, as well as methods and compositions for tumor radiotherapy.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: January 18, 2005
    Assignee: Theseus Imaging, Corp.
    Inventor: Allan M. Green
  • Method of imaging cell death in vivo
    Publication number: 20040170603
    Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described. Methods for tumor radiotherapy are also provided.
    Type: Application
    Filed: March 5, 2004
    Publication date: September 2, 2004
    Applicants: The Board of Trustees of the Leland Stanford Junior University, Theseus Imaging Corporation
    Inventors: H. William Strauss, Francis G. Blankenberg, Allan M. Green, Neil Steinmetz
  • Methods and compositions to treat glycosaminoglycan-associated molecular interactions
    Publication number: 20040096453
    Abstract: Therapeutic compounds and methods for inhibiting a glycosaminoglycan (GAG)-associated molecular interaction in a subject, whatever its clinical setting, are described
    Type: Application
    Filed: October 20, 2003
    Publication date: May 20, 2004
    Applicant: Neurochem (International) Limited
    Inventors: Robert Kisilevsky, Allan M. Green, Francine Gervais
  • Method of imaging cell death in vivo
    Patent number: 6726895
    Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described. Methods for tumor radiotherapy are also provided.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: April 27, 2004
    Assignees: Board of Trustees of the Leland Stanford Junior University, Theseus Imaging Corporation
    Inventors: H. William Strauss, Francis G. Blankenberg, Allan M. Green, Neil Steinmetz
  • Methods of preparing an anti-tumor vaccine
    Publication number: 20040071739
    Abstract: A method of preparing an autologous anti-tumor vaccine by chemically linking a tumor or anti-microbial extract with a shiga-like toxin B fragment.
    Type: Application
    Filed: March 25, 2003
    Publication date: April 15, 2004
    Applicant: Select Therapeutics, Inc.
    Inventor: Allan M. Green
  • Verotoxin B subunit for immunization
    Publication number: 20040013681
    Abstract: Methods for stimulating an immune response in a mammal by administering a toxin-antigen conjugate are provided. Pharmaceutical compositions and methods for treating an antigen-related state are also described.
    Type: Application
    Filed: February 13, 2003
    Publication date: January 22, 2004
    Applicant: Select Therapeutics, Inc.
    Inventor: Allan M. Green
  • Compounds and methods for modulating cerebral amyloid angiopathy
    Patent number: 6670399
    Abstract: The invention provides methods of inhibiting cerebral amyloid angiopathy. The invention further provides methods of treating a disease state characterized by cerebral amyloid angiopathy in a subject with an A&bgr;40 inhibitor having the structure: Q-[—SO3−X+]n or Q-[—OSO3−X+]n wherein Q is a carrier group; X+ is a cationic group; and n is one.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: December 30, 2003
    Assignee: Neurochem (International) Limited
    Inventors: Allan M. Green, Francine Gervais
  • Methods for using annexin for detecting cell death in vivo and treating associated conditions
    Publication number: 20030202939
    Abstract: The present invention provides methods and compositions for imaging cell death in vivo, as well as methods and compositions for tumor radiotherapy.
    Type: Application
    Filed: April 7, 2003
    Publication date: October 30, 2003
    Applicant: Theseus Imaging Corporation
    Inventor: Allan M. Green
  • Methods of using labelled verotoxin B subunit
    Publication number: 20030103897
    Abstract: The invention pertains to methods for labeling antigen presenting cells, by contacting the antigen presenting cells with a labeled verotoxin. The invention also pertains to methods for determining the ability of an antigen presenting cell to stimulate an immune response.
    Type: Application
    Filed: May 15, 2002
    Publication date: June 5, 2003
    Inventor: Allan M. Green
  • Method of imaging cell death in vivo
    Publication number: 20030003047
    Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described. Methods for tumor radiotherapy are also provided.
    Type: Application
    Filed: April 3, 2002
    Publication date: January 2, 2003
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: H. W. Strauss, Francis G. Blankenberg, Allan M. Green, Neil Steinmetz
  • Compounds and methods for modulating cerebral amyloid angiopathy
    Publication number: 20030003141
    Abstract: The invention provides methods of inhibiting cerebral amyloid angiopathy. The invention further provides methods of treating a disease state characterized by cerebral amyloid angiopathy in a subject.
    Type: Application
    Filed: December 22, 2000
    Publication date: January 2, 2003
    Inventors: Allan M. Green, Francine Gervais
  • Methods for using annexin for detecting cell death in vivo and treating associated conditions
    Publication number: 20020192162
    Abstract: The present invention provides methods and compositions for imaging cell death in vivo, as well as methods and compositions for tumor radiotherapy.
    Type: Application
    Filed: April 3, 2002
    Publication date: December 19, 2002
    Applicant: Thesus Imaging Corporation
    Inventor: Allan M. Green
  • Methods and compositions to treat glycosaminoglycan-associated molecular interactions
    Publication number: 20020193395
    Abstract: Therapeutic compounds and methods for inhibiting a glycosaminoglycan (GAG)-associated molecular interaction in a subject, whatever its clinical setting, are described.
    Type: Application
    Filed: October 2, 2001
    Publication date: December 19, 2002
    Applicant: Queen's University
    Inventors: Robert Kisilevsky, Allan M. Green, Francine Gervais
  • VEROTOXIN B SUBUNIT FOR IMMUNIZATION
    Publication number: 20020081307
    Abstract: Methods for stimulating an immune response in a mammal by administering a toxin-antigen conjugate are provided. Pharmaceutical compositions and methods for treating an antigen-related state are also described.
    Type: Application
    Filed: May 14, 1999
    Publication date: June 27, 2002
    Inventor: ALLAN M. GREEN
  • Methods and compositions to treat glycosaminoglycan-associated molecular interactions
    Patent number: 6310073
    Abstract: Therapeutic compounds and methods for inhibiting a glycosaminoglycan (GAG)-associated molecular interaction in a subject, whatever its clinical setting, are described.
    Type: Grant
    Filed: July 27, 1999
    Date of Patent: October 30, 2001
    Assignees: Queen's University at Kingston, Neurochem, Inc.
    Inventors: Robert Kisilevsky, Allan M. Green, Francine Gervais
  • Pharmaceutical compositions containing chondroitinase and uses therefor
    Patent number: 6200564
    Abstract: Gastrointestinal mucus from patients suffering from cystic fibrosis has been found to contain large amounts of chondroitin sulfate polymer. This finding indicates that the enzyme chondroitinase is useful for preventing gastrointestinal mucus from accumulating in cystic fibrosis patients, and subjects suffering from other diseases or conditions characterized by excess mucus secretion.
    Type: Grant
    Filed: April 10, 1998
    Date of Patent: March 13, 2001
    Inventors: J. Thomas Lamont, K. Ramakrishnan Bhaskar, Allan M. Green